Durham VA Medical Center, Durham, NC
Durham, North Carolina, 27705-3875, United States
Location contact
Heidi D Bassani
CONTACT
Kelli Dominick Allen, PhD
PRINCIPAL_INVESTIGATOR
Susanna B Oberg, AAS AAS
CONTACT
NCT Number: NCT07219732
This project, conducted within the Department of Veterans Affairs Healthcare System (VHA), will test the effectiveness of an intervention to improve adherence to home exercise among Veterans receiving physical therapy (PT) for knee osteoarthritis (OA). The intervention, "Boosting Exercise Adherence in Knee Osteoarthritis" (BOOST-OA), has two phases. During the initiation phase (first 3 months of PT care), patients will receive tools and activities to address outcome expectations, action self-efficacy, goal-setting and monitoring. During the behavior maintenance phase (starting after PT care and continuing for 9 months), patients will receive health coaching calls that address satisfaction with outcomes, relapse prevention planning and independent monitoring. There are three main study aims: (1) examine improvements in patient outcomes, such as physical function, following BOOST-OA; (2) explore patient characteristics that lead to difference in reported improvements; and (3) interview participants and clinicians about their experience with BOOST-OA to inform future implementation.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Durham, North Carolina, 27705-3875, United States
Heidi D Bassani
CONTACT
Kelli Dominick Allen, PhD
PRINCIPAL_INVESTIGATOR
Susanna B Oberg, AAS AAS
CONTACT
In this project, the investigators will test the effectiveness of a theoretically-informed, scalable intervention to enhance adherence to home exercise among Veterans receiving PT for knee OA. "Boosting Exercise Adherence in Knee Osteoarthritis" (BOOST-OA) includes components that address both exercise behavior initiation (conducted in conjunction with the PT episode of care) and maintenance (conducted after completion of PT care). Specifically, BOOST-OA includes: 1) Tools and activities woven into PT visits that address outcome expectations, action self-efficacy, goal-setting and monitoring (3-month behavior initiation phase) and 2) Health coaching calls that address satisfaction with outcomes, relapse prevention planning and independent monitoring (9-month behavior maintenance phase). This project is being conducted within the Department of Veterans Affairs Healthcare system (VHA). Specific aims are:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
UC will be delivered by trained clinicians at participating sites. The study team will provide clinicians with guidance and training to standardize core aspects of PT, aligned with best practice recommendations. Clinicians must provide enrolled Veterans with at least 4 PT visits, spaced at least weekly so that Veterans can practice home exercise and receive guidance in exercise progression. All PT visits must be completed within 3 months.
BOOST-OA includes components that are integrated into PT visits (concurrent), focused on behavior initiation, as well as components that occur after PT visits have ended (sequential), focused on behavior maintenance. Concurrent components will be delivered in conjunction with usual care PT visits. Clinicians must provide enrolled Veterans with at least 4 PT visits, spaced at least weekly. PT visits must be also completed within 3 months. Sequential components will be delivered by a health coach via phone or video. Health coach sessions will be conducted every other week for the first 2 months (months 4-5), monthly for an additional 3 months (months 6- 8), and every other month for the last 4 months (months 9-12; 9 total contacts). Calls will address strengthening and stretching exercises (≥3 times per week), as well as overall physical activity (e.g., minutes / steps).
Time frame: Baseline
The investigators selected physical function as the primary outcome because of its high importance to individuals with knee OA and its relevance for PT and exercise-based interventions. The WOMAC has been used widely in the context of clinical trials for knee OA and has well established psychometric properties including reliability, construct validity, internal consistency, and sensitivity to change in the context of behavioral interventions for knee OA. The WOMAC function subscale consists of 17 items rated on a Likert scale of 0 (no difficulty) to 4 (extreme difficulty).
Time frame: Change from baseline to 3-months
The investigators selected physical function as the primary outcome because of its high importance to individuals with knee OA and its relevance for PT and exercise-based interventions. The WOMAC has been used widely in the context of clinical trials for knee OA and has well established psychometric properties including reliability, construct validity, internal consistency, and sensitivity to change in the context of behavioral interventions for knee OA. The WOMAC function subscale consists of 17 items rated on a Likert scale of 0 (no difficulty) to 4 (extreme difficulty).
Time frame: Change from baseline to 12-months (primary outcome time point)
The investigators selected physical function as the primary outcome because of its high importance to individuals with knee OA and its relevance for PT and exercise-based interventions. The WOMAC has been used widely in the context of clinical trials for knee OA and has well established psychometric properties including reliability, construct validity, internal consistency, and sensitivity to change in the context of behavioral interventions for knee OA. The WOMAC function subscale consists of 17 items rated on a Likert scale of 0 (no difficulty) to 4 (extreme difficulty).
Time frame: Change from baseline to 18-months
The investigators selected physical function as the primary outcome because of its high importance to individuals with knee OA and its relevance for PT and exercise-based interventions. The WOMAC has been used widely in the context of clinical trials for knee OA and has well established psychometric properties including reliability, construct validity, internal consistency, and sensitivity to change in the context of behavioral interventions for knee OA. The WOMAC function subscale consists of 17 items rated on a Likert scale of 0 (no difficulty) to 4 (extreme difficulty).
Time frame: Change from baseline to 24-months
The investigators selected physical function as the primary outcome because of its high importance to individuals with knee OA and its relevance for PT and exercise-based interventions. The WOMAC has been used widely in the context of clinical trials for knee OA and has well established psychometric properties including reliability, construct validity, internal consistency, and sensitivity to change in the context of behavioral interventions for knee OA. The WOMAC function subscale consists of 17 items rated on a Likert scale of 0 (no difficulty) to 4 (extreme difficulty).
Time frame: Baseline
This modified version of the Patient Specific Functional Scale will ask participants to identify one important activity they are unable to do or are having difficulty with as a result of their knee OA. They then rate their ability to perform the identified activity from 0=unable to perform to 10=able to perform at the same level as before having knee OA.
Time frame: Baseline
The number of times that a participant can stand up from a seated position and sit back down in 30-seconds.
Time frame: Baseline
The number of times a participant can step in place in a 2-minute period.
Time frame: Baseline
In addition to the WOMAC function subscale, the investigators will assess the WOMAC pain subscale (score range 0-20, higher scores indicate greater pain severity).
Time frame: Baseline
The investigators will combine WOMAC subscales to calculate a total score (score range 0-96, higher scores indicate greater pain, stiffness, and functional limitation).
Time frame: Change from baseline to 3-months
This modified version of the Patient Specific Functional Scale will ask participants to identify one important activity they are unable to do or are having difficulty with as a result of their knee OA. They then rate their ability to perform the identified activity from 0=unable to perform to 10=able to perform at the same level as before having knee OA.
Time frame: Baseline
The investigators will utilize validated algorithms to calculate average minutes of light and moderate-to-vigorous physical activity per day assessed by accelerometer.
Time frame: Change from baseline to 12-months (primary outcome time point)
This modified version of the Patient Specific Functional Scale will ask participants to identify one important activity they are unable to do or are having difficulty with as a result of their knee OA. They then rate their ability to perform the identified activity from 0=unable to perform to 10=able to perform at the same level as before having knee OA.
Time frame: Change from baseline to 18-months
This modified version of the Patient Specific Functional Scale will ask participants to identify one important activity they are unable to do or are having difficulty with as a result of their knee OA. They then rate their ability to perform the identified activity from 0=unable to perform to 10=able to perform at the same level as before having knee OA.
Time frame: Change from baseline to 24-months
This modified version of the Patient Specific Functional Scale will ask participants to identify one important activity they are unable to do or are having difficulty with as a result of their knee OA. They then rate their ability to perform the identified activity from 0=unable to perform to 10=able to perform at the same level as before having knee OA.
Time frame: Change from baseline to 12-months (primary outcome time point)
The investigators will utilize validated algorithms to calculate average minutes of light and moderate-to-vigorous physical activity per day assessed by accelerometer.
Time frame: Change from baseline to 24-months
The investigators will utilize validated algorithms to calculate average minutes of light and moderate-to-vigorous physical activity per day assessed by accelerometer.
Time frame: Change from baseline to 3-months
The number of times that a participant can stand up from a seated position and sit back down in 30-seconds.
Time frame: Change from baseline to 12-months (primary outcome time point)
The number of times that a participant can stand up from a seated position and sit back down in 30-seconds.
Time frame: Change from baseline to 18-months
The number of times that a participant can stand up from a seated position and sit back down in 30-seconds.
Time frame: Change from baseline to 24-months
The number of times that a participant can stand up from a seated position and sit back down in 30-seconds.
Time frame: Change from baseline to 3-months
The number of times a participant can step in place in a 2-minute period.
Time frame: Change from baseline to 12-months (primary outcome time point)
The number of times a participant can step in place in a 2-minute period.
Time frame: Change from baseline to 18-months
The number of times a participant can step in place in a 2-minute period.
Time frame: Change from baseline to 24-months
The number of times a participant can step in place in a 2-minute period.
Time frame: Change from baseline to 3-months
In addition to the WOMAC function subscale, the investigators will assess the WOMAC pain subscale (score range 0-20, higher scores indicate greater pain severity).
Time frame: Change from baseline to 12-months (primary outcome time point)
In addition to the WOMAC function subscale, the investigators will assess the WOMAC pain subscale (score range 0-20, higher scores indicate greater pain severity).
Time frame: Change from baseline to 18-months
In addition to the WOMAC function subscale, the investigators will assess the WOMAC pain subscale (score range 0-20, higher scores indicate greater pain severity).
Time frame: Change from baseline to 24-months
In addition to the WOMAC function subscale, the investigators will assess the WOMAC pain subscale (score range 0-20, higher scores indicate greater pain severity).
Time frame: Change from baseline to 3-months
The investigators will combine WOMAC subscales to calculate a total score (score range 0-96, higher scores indicate greater pain, stiffness, and functional limitation).
Time frame: Change from baseline to 12-months (primary outcome time point)
The investigators will combine WOMAC subscales to calculate a total score (score range 0-96, higher scores indicate greater pain, stiffness, and functional limitation).
Time frame: Change from baseline to 18-months
The investigators will combine WOMAC subscales to calculate a total score (score range 0-96, higher scores indicate greater pain, stiffness, and functional limitation).
Time frame: Change from baseline to 24-months
The investigators will combine WOMAC subscales to calculate a total score (score range 0-96, higher scores indicate greater pain, stiffness, and functional limitation).
Time frame: Baseline
The investigators will utilize validated algorithms to calculate average steps per day assessed by accelerometer.
Time frame: Change from baseline to 12-months (primary outcome time point)
The investigators will utilize validated algorithms to calculate average steps per day assessed by accelerometer.
Time frame: Change from baseline to 24-months
The investigators will utilize validated algorithms to calculate average steps per day assessed by accelerometer.
Contact information is provided by the study sponsor or research team.
Jennifer M Gierisch, PhD MA
CONTACT
(919) 286-0411 ext. 177330
Kelli D Allen, PhD
CONTACT
(919) 286-0411 ext. 7090
VA Office of Research and Development
Fed
Boosting Exercise Adherence in Knee Osteoarthritis (BOOST-OA)
Acronym: BOOST-OA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06522906
Arthritis, Behavior
Tucson, Arizona, United States
View Trial DetailsNCT06173193
Arthritis, Behavior
Jyväskylä, Finland
View Trial DetailsNCT06269549
Arthritis, Behavior
Izola, Slovenia
View Trial DetailsNCT06414473
Arthritis, Behavior
Gainesville, Florida, United States
View Trial Details